Cathie Wood’s Ark keeps selling one stock once again
By Mwangi Enos
Published on April 15, 2026.
Ark Investment Management, the head of the firm that sells shares of Strata Critical Medical (NASDAQ: SRTA), has continued to reduce its exposure to the company. The firm sold 182,767 shares worth about $738,378 across its ARKQ and ARKX exchange-traded funds on April 13. This move is part of a larger portfolio rebalancing strategy, suggesting a systematic reduction in Strata's exposure. Co-CEO and COO Will Heyburn noted that the company is still exceeding its growth targets and is gaining strength, not losing it. Despite this, Ark has been actively buying stocks related to artificial intelligence, fintech, and genomics.
Related Articles
Dusty Baker Pulls Back the Curtain on Luxury Real Estate To Reveal the Grit Behind the Glamour
Dusty Baker reveals a gritty, yet glamorous side of high-end real estate, balancing work with family life, community involvement, and daily commute.
Bitcoin’s (BTC) 50% drawdown may have marked a bottom as on-chain signals turn bullish
The RHODL ratio, tracking long-term and short-term bitcoin holdings, is indicating a bottom, with potential for further declines due to speculative activity.
U.S. Treasury yields steady as traders monitor Middle East de-escalation
U.S. Treasury yields were unchanged as investors monitored the Middle East ceasefire, with investors also focusing on potential interest rate changes and oil prices falling.